The
global d-mannose market is dominated by players such as Now Health
Group Inc., Nutraceutical International Corp., E. I. du Pont de
Nemours and Company, and Jarrow Formulas Inc. While these players are
likely to establish dominant shares in the global d-mannose market in
the coming years, the nascent origin of the market has made it highly
lucrative for new entrants. Other key players in the global d-mannose
market include VWR Corporation, Atrium Innovations Inc., Ferro
Pfanstiehl Laboratories, Inc., Hänseler AG, Kyowa Hakko Kirin Co
Ltd, and Bio-Tech Pharmacal Inc. Expansion of manufacturing capacity
is likely to remain a key growth avenue for players in the global
d-mannose market in the coming years, with larger players likely to
target smaller players in emerging markets in order to make the most
of the burgeoning opportunity in developing regions.
Download
exclusive Sample of this report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14363
According
to Transparency Market Research (TMR), the global d-mannose market is
likely to exhibit a CAGR of 3.5% from 2017 to 2025. The global
d-mannose market was valued at US$774.5 mn in 2017 and is likely to
rise to US$1,016.7 mn by the end of 2025.
By
application, dietary supplements dominate the global d-mannose
market, with pharmaceuticals and functional food also likely to
contribute significantly to the global market’s growth in the
coming years. The dietary supplements segment is likely to grow to a
revenue valuation of US$440.5 mn by 2025, representing more than 40%
of the global d-mannose market. Functional food, on the other hand,
is likely to exhibit the highest CAGR, with the segment expected to
grow at 4% over the 2017-2025 forecast period.
Increasing
Prevalence of UTIs in Developed Countries Drives D-Mannose Market
One
of the prime drivers for the global d-mannose market is the growing
awareness of the utility of d-mannose, which is a form of glucose but
with several differing chemical characteristics, in preventing
urinary tract infections (UTIs). Unlike glucose, mannose has the
property of clinging to the walls of the urinary tract, making it
harder for pathogens to attach themselves to the surface. This makes
it the perfect preventive tool for UTIs, as UTIs are usually treated
with antibiotics, several of which are facing consistent resistance.
The
global
d-mannose market has also gained a significant part of its
demand from products designed for diabetic or other calorie-conscious
demographics, as mannose is not metabolized like glucose in the body
and thus doesn’t contribute to the blood sugar levels. Most of
d-mannose is absorbed in the preliminary parts of the digestive
tract, making it safe for diabetic individuals. The growing scope of
specialist diets due to the rapid development of long-distance
shipping facilities is thus likely to help the global d-mannose
market.
North
America has emerged as the leading contributor to the global
d-mannose market. The growing prevalence of urinary tract infections
in North America has fueled the development of alternative treatments
such as d-mannose. The growing availability of healthcare information
to the masses has also helped the growth of the d-mannose market as
an alternative or supplementary to conventional UTI treatments. The
high prevalence of diabetes in regions such as the U.S. is also
likely to remain a key driver for the d-mannose market in North
America in the coming years. The growing prevalence of diabetes in
Southeast Asia is also likely to be vital for the global d-mannose
market.
